Apararenone (MT-3995) (Synonyms: MT-3995) |
Catalog No.GC31448 |
아파라레논(MT-3995)(MT-3995)은 당뇨병성 신병증 및 비알코올성 지방간염 치료를 위해 개발 중인 새로운 비스테로이드성 무기질코르티코이드 수용체 길항제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 945966-46-1
Sample solution is provided at 25 µL, 10mM.
Apararenone (MT-3995) is a novel non-steroidal mineralocorticoid receptor antagonists under development for the treatment of diabetic nephropathies and non-alcoholic steatohepatitis.
Recently, a phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan[1].
[1]. Kolkhof P, et al. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development. J Endocrinol. 2017 Jul;234(1):T125-T140.
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *